Assefa Mengesha | pharmacology | Best Researcher Award

Published on by Cognitive Scientist Awards

Mr. Assefa Mengesha | pharmacology | Best Researcher Award 🏆

Lecturer at University of Gondar, College of Medicine and Health Sciences, Ethiopia.

Assefa Kebad Mengesha, a Lecturer in the Department of Pharmacology at the University of Gondar, has over a decade of experience in teaching and research. Holding an MSc in Pharmacology, he has made notable contributions to health-related research and education. Assefa has published 13 papers in indexed journals (Scopus, PubMed) and has been active in curriculum development and student mentorship. Despite limited involvement in consultancy, collaborations, and industry projects, his research has advanced knowledge in pharmacology, particularly in health-related disorders and education.

Profile

Scopus

Education 🎓:

Assefa Kebad Mengesha completed his Master of Science (MSc) in Pharmacology from the University of Gondar, Ethiopia. His education laid a strong foundation in pharmacology, emphasizing health-related disorder management, drug mechanisms, and medical education. His academic training involved rigorous coursework, laboratory experiments, and independent research projects that contributed to his expertise in the field. During his graduate studies, he developed an interest in integrating research findings into teaching methodologies, enhancing the learning experience for students. His focus on health-related pharmacological studies during his MSc program enabled him to contribute significantly to addressing local and global health challenges. Assefa’s academic background is complemented by his continuous learning through professional development programs and his commitment to staying updated with the latest advancements in pharmacology. His education is a testament to his dedication to excellence in teaching, research, and the practical application of pharmacological knowledge.

Work Experience đź’Ľ:

Assefa Kebad Mengesha has over 10 years of academic and research experience at the University of Gondar, Ethiopia. As a lecturer in the Department of Pharmacology, he has been instrumental in teaching undergraduate and graduate students, focusing on health-related pharmacology and education. He has mentored numerous students, guiding them through research projects and helping them achieve academic success. Assefa has also contributed to curriculum development, ensuring that teaching materials align with current research trends and industry needs. His experience includes conducting pharmacological research that has led to 13 publications in reputable indexed journals. Beyond his teaching and research roles, Assefa has participated in various academic committees, fostering collaboration and innovation within his institution. His extensive experience underscores his commitment to education, research excellence, and the advancement of pharmacology as a discipline.

Awards and Honors

Although there are no specific awards or honors listed in his current profile, Assefa Kebad Mengesha’s contributions to pharmacological research and education reflect a career deserving of recognition. His 13 published articles in reputable journals indexed in Scopus and PubMed signify his academic commitment and scholarly excellence. Additionally, his role in mentoring students and developing innovative curricula at the University of Gondar highlights his dedication to advancing education. Assefa’s decade-long experience in pharmacology education and research positions him as a valuable asset to his academic community. Future awards and honors would further validate his contributions and solidify his standing as a respected educator and researcher. He remains focused on expanding his impact through continued research and professional development.

Research Interests:

Assefa Kebad Mengesha’s research focuses on health-related pharmacology and education, addressing critical challenges in medical sciences. His primary interest lies in investigating pharmacological mechanisms and interventions for managing health disorders. By integrating innovative methodologies and evidence-based approaches, his research aims to enhance the understanding and treatment of health-related issues. Assefa has also explored educational strategies in pharmacology, emphasizing the integration of research findings into teaching practices to foster a robust learning environment for students. Over the years, his work has resulted in 13 publications in reputable indexed journals, contributing to the global body of knowledge in pharmacology. His interdisciplinary approach, combining pharmacology and education, reflects his commitment to improving healthcare outcomes and advancing medical education. Assefa’s research aligns with his broader goal of bridging the gap between theoretical pharmacology and its practical application in healthcare settings.

📚 Publications 

    • Assessing the effectiveness of flipped classroom teaching–learning method among undergraduate medical students at Gondar University, College of Medicine and Health Sciences: An interventional study
      Authors: Mengesha, A.K., Ayele, H.S., Misker, M.F., Beyna, A.T.
      Citations: 0
      Year: 2024
    • Symptoms of posttraumatic stress, anxiety, and depression, along with their associated factors, among Eritrean refugees in Dabat Town, Northwest Ethiopia, 2023
      Authors: Melese, M., Simegn, W., Esubalew, D., Mengesha, A.K., Gela, Y.Y.
      Citations: 0
      Year: 2024
    • Evaluation of community pharmacy technicians’ knowledge, attitudes, and practices about erectile dysfunction and its predictors in Gondar Town: A cross-sectional descriptive study
      Authors: Mengesha, A.K., Workie Limenh, L., Ayenew, W., Esubalew, D., Beyna, A.T.
      Citations: 0
      Year: 2024
    • Evaluation of wound healing and anti-inflammatory activity of hydro-alcoholic extract and solvent fractions of the leaves of Clerodendrum myricoides (Lamiaceae) in mice
      Authors: Beyna, A.T., Mengesha, A.K., Yefter, E.T., Kahaliw, W.
      Citations: 0
      Year: 2024
    • Cross-cultural adaptation, content validity, and reliability of the Amharic version of the modified John-Hopkins fall risk assessment scale among older adults who attend home health care services
      Authors: Chanie, S.T., Gashaw, M., Shiferaw, K.B., Abriham, Z.Y., Dejen Takele, M.
      Citations: 0
      Year: 2024
    • Poor sleep quality and associated factors among adult chronic kidney disease patients
      Authors: Gela, Y.Y., Limenh, L.W., Simegn, W., Mengesha, A.K., Melese, M.
      Citations: 0
      Year: 2024
    • Prescription pattern and associated factors among pregnant women attending antenatal clinics in University of Gondar, North West Ethiopia
      Authors: Belete, T.M., Gashaw Sisay, Mengesha, E., Mengesha, A.K., Basazin, A.
      Citations: 1
      Year: 2022
    • Anti-Diarrheal Activities of Hydromethanolic Crude Extract and Solvent Fractions of Acacia seyal (Fabaceae) Roots in Mice [Response to Letter]
      Authors: Mengesha, A.K., Birru, E.M., Adugna, M.
      Citations: 1
      Year: 2022
    • Anti-Diarrheal Activities of Hydromethanolic Crude Extract and Solvent Fractions of Acacia seyal (Fabaceae) Roots in Mice
      Authors: Mengesha, A.K., Birru, E.M., Adugna, M.
      Citations: 0
      Year: 2022

Conclusion 

While Assefa Kebad Mengesha demonstrates a strong foundation in teaching and research with significant contributions to pharmacology, his application for the Best Researcher Award might benefit from broader engagement in consultancy, innovation, and professional networking. His academic record aligns well with the award’s objectives, but addressing the identified areas for improvement would make him a more competitive candidate.

 

 

Joanna Bartkowiak-Wieczorek | pharmacogenetics | Best Researcher Award

Published on by Cognitive Scientist Awards

 Dr. Joanna Bartkowiak-Wieczorek | pharmacogenetics | Best Researcher Award 🏆

Physiology Department at Poznan University of Medical Sciences🎓

Dr. Joanna Bartkowiak-Wieczorek is a distinguished pharmacogeneticist and Assistant Professor at the Medical University of Karol Marcinkowski in Poznań. She holds a Master’s in Biological Sciences from Adam Mickiewicz University, where she first explored molecular biology, and earned her Ph.D. at the Medical University of Poznań, focusing on genetic markers related to osteoporosis. With expertise in pharmacogenetics, biochemistry, and molecular biology, Dr. Bartkowiak-Wieczorek’s research examines gene-drug interactions and plant-based compounds, particularly cannabinoids in oncology. A committed educator, she teaches pharmacology and quality management, instilling rigorous standards in future healthcare professionals. Her work in personalized medicine and dedication to research quality has garnered significant recognition and establishes her as a leading figure in pharmacogenetics.

 

Professional Profile 

Education 🎓:

Dr. Joanna Bartkowiak-Wieczorek holds a Master of Science in Biological Sciences from Adam Mickiewicz University, Poznań, where she specialized in molecular biology, conducting research on modified DNA bases. She earned her Ph.D. from the Medical University of Poznań and Adam Mickiewicz University, focusing on genetic polymorphisms related to osteoporosis risk. Her doctoral work on estrogen and calcitonin receptors laid the foundation for her expertise in pharmacogenetics.

Work Experience đź’Ľ:

Dr. Bartkowiak-Wieczorek is currently an Assistant Professor and research staff member at the Medical University of Karol Marcinkowski in Poznań, where she has been teaching and conducting research since 2018. Previously, she worked at the Medical University of Poznań, focusing on pharmacogenetics research and quality management in drug development. She also contributed to the Institute of Natural Fibres and Medicinal Plants, Poznań, implementing ISO and GMP standards, which supports her commitment to rigorous quality in research and clinical practices.

Skills 🔍

Dr. Bartkowiak-Wieczorek is skilled in pharmacogenetic analysis, biochemistry, and molecular biology techniques, including DNA isolation, PCR, and ELISA. She has a strong foundation in quality management, having implemented GMP, ISO 9001, and ISO 17025 standards in clinical and preclinical studies. Her expertise also extends to pharmacogenetic testing, pharmacotherapy, and plant-based compound analysis, notably with cannabinoids.

Awards and Honors 🏆

Dr. Bartkowiak-Wieczorek is skilled in pharmacogenetic analysis, biochemistry, and molecular biology techniques, including DNA isolation, PCR, and ELISA. She has a strong foundation in quality management, having implemented GMP, ISO 9001, and ISO 17025 standards in clinical and preclinical studies. Her expertise also extends to pharmacogenetic testing, pharmacotherapy, and plant-based compound analysis, notably with cannabinoids.

🤝 Memberships:

Dr. Bartkowiak-Wieczorek is actively involved in several scientific communities, contributing her knowledge in biochemistry, pharmacology, and personalized medicine. Her collaborative work with institutions such as the National Science Centre and participation in interdisciplinary research projects demonstrate her dedication to advancing pharmacogenetics and biopharmacy.

Teaching Experience 👩‍🏫:

She has extensive teaching experience, instructing students in various programs, including Medicine, Pharmacy, and Dentistry, at the Medical University of Karol Marcinkowski. Her courses cover human physiology, pharmacology, pharmacogenetics, and quality management, reflecting her comprehensive approach to teaching future medical professionals.

Research Focus 🔬:

Dr. Bartkowiak-Wieczorek’s research centers on pharmacogenetics, particularly the interaction of genetics with drug efficacy and safety. She explores plant-based compounds, with a specific focus on cannabinoids and their applications in oncology and chronic disease management. Her research projects include studies on gene expression, drug interactions, and the pharmacokinetics of pediatric treatments, which contribute to the field of personalized medicine.

Conclusion 

Dr. Joanna Bartkowiak-Wieczorek is a highly deserving candidate for the Best Researcher Award. Her pioneering work in pharmacogenetics, coupled with her dedication to research quality, personalized medicine, and plant-based medicinal compounds, underscores her profound impact on modern pharmacology. Expanding her research outreach and international collaborations could further amplify her contributions, solidifying her role as a leader in personalized medicine.

📚 Publilcation 

  • Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat
    2024, Biomolecules, 14(9), 1065
  • Methylsulfinyl Hexyl Isothiocyanate (6-MSITC) from Wasabi Is a Promising Candidate for the Treatment of Cancer, Alzheimer’s Disease, and Obesity
    2024, Nutrients, 16(15), 2509
  • The Dual Faces of Oestrogen: The Impact of Exogenous Oestrogen on the Physiological and Pathophysiological Functions of Tissues and Organs
    2024, International Journal of Molecular Sciences, 25(15), 8167
  • Natural Products and Health
    2024, Nutrients, 16(3), 415
  • THC-Reduced Cannabis sativa L.—How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?
    2023, Nutrients, 15(12), 2646
  • Krytyczne spojrzenie na nowe moĹĽliwoĹ›ci zastosowania terapeutycznego statyn – podsumowanie aktualnego stanu wiedzy
    2023, Farmacja Polska, 79(5), 297-315
  • The Dark Side of Iron: The Relationship between Iron, Inflammation and Gut Microbiota in Selected Diseases Associated with Iron Deficiency Anaemia—A Narrative Review
    2022, Nutrients, 14(17), 3478
  • High-fat, Western-style diet, systemic inflammation, and gut microbiota: A narrative review
    2021, Cells, 10(11), 3164
  • The Effect of Genetic Variations for Interleukin-10 (IL-10) on the Efficacy of Immunosuppressive Therapy in Patients after Kidney Transplantation
    2020, International Immunopharmacology, 89, 107059
  • The Effect of Different Water Extracts from Platycodon grandiflorum on Selected Factors Associated with Pathogenesis of Chronic Bronchitis in Rats
    2020, Molecules (Basel, Switzerland), 25(21)B

 

 

Joanna Bartkowiak-Wieczorek | Pharmacology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Joanna Bartkowiak-Wieczorek | Pharmacology | Best Researcher Award 🏆

Poznan University of Medical Sciences, Poland🎓

Dr.Joanna Bartkowiak-Wieczorek is an accomplished researcher and Assistant Professor at the Medical University of Karol Marcinkowski in PoznaĹ„, specializing in pharmacology and pharmacogenetics. With a strong focus on cannabinoids and their potential medical applications, particularly in oncology and personalized medicine, she has contributed significantly to understanding how genetic factors influence drug response. Joanna’s work has been recognized with the Best Researcher Award, reflecting her dedication to advancing pharmacological research and education. She is committed to bridging the gap between scientific inquiry and clinical practice, enhancing the safety and efficacy of pharmacotherapy for diverse patient populations.

 

Professional Profile 

 

🎓 Education

Joanna Bartkowiak-Wieczorek holds a Master of Science in Biological Sciences from Adam Mickiewicz University in Poznań, specializing in molecular biology. She completed her PhD at the Medical University of Poznań, focusing on epigenetic modifications in hybrids of green frogs and the polymorphism of genes associated with osteoporosis risk.

🏢 Work Experience

Since September 2018, she has served as an Assistant Professor at the Medical University of Karol Marcinkowski in Poznań, where she conducts research and teaches various programs in human physiology. Prior to this, she worked as scientific and technical staff at the Medical University of Poznań, conducting pharmacogenetic research and educational classes. She also held roles focused on quality management systems at the Institute of Natural Fibres and Medicinal Plants, contributing to the implementation of GMP and ISO standards.

 

Awards and Honors 🏆

Joanna has participated in various research projects funded by the National Science Centre, focusing on pharmacogenetics and the development of technologies for cannabinoid extraction for cancer treatment. Her contributions to scientific knowledge have been recognized through numerous publications in reputable journals, reflecting her commitment to advancing research in her field.

🔬 Research Focus

Joanna’s research primarily explores cannabinoids, their pharmacological properties, and applications in oncology and personalized medicine. She has conducted significant studies on the influence of individual genes on drug responses and has a strong background in pharmacogenetics, drug interactions, and the therapeutic potential of plant-based compounds.

Conclusion 

Joanna’s qualifications and achievements position her as a leading figure in her field, making her a suitable candidate for the Best Researcher Award. By addressing the identified areas for improvement, she could further enhance her research impact and continue to contribute to advancements in pharmacology and personalized medicine.

📚 Publilcation 

  1. Bartkowiak-Wieczorek, J., et al. (2024). Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat. Biomolecules. DOI: 10.3390/biom14091065
  2. Bartkowiak-Wieczorek, J., et al. (2024). Methylsulfinyl Hexyl Isothiocyanate (6-MSITC) from Wasabi: A Promising Candidate for Cancer, Alzheimer’s Disease, and Obesity Treatment. Nutrients. DOI: 10.3390/nu16152509
  3. Bartkowiak-Wieczorek, J., et al. (2024). The Dual Faces of Oestrogen: The Impact of Exogenous Oestrogen on Physiological and Pathophysiological Functions of Tissues and Organs. International Journal of Molecular Sciences. DOI: 10.3390/ijms25158167
  4. Bartkowiak-Wieczorek, J., et al. (2024). Natural Products and Health. Nutrients. DOI: 10.3390/nu16030415
  5. Bartkowiak-Wieczorek, J. (2023). A Critical Look at New Possibilities of Therapeutic Use of Statins: A Summary of Current Knowledge. Farmacja Polska. DOI: 10.32383/farmpol/174070
  6. Bartkowiak-Wieczorek, J., et al. (2023). THC-Reduced Cannabis sativa L.—How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?. Nutrients. DOI: 10.3390/nu15122646
  7. Bartkowiak-Wieczorek, J., et al. (2022). The Dark Side of Iron: The Relationship Between Iron, Inflammation, and Gut Microbiota in Diseases Associated with Iron Deficiency Anaemia. Nutrients. DOI: 10.3390/nu14173478
  8. Bartkowiak-Wieczorek, J. (2022). Polygraph Analyses: Technical and Practical Background. Journal of Medical Science. DOI: 10.20883/medical.e590
  9. Bartkowiak-Wieczorek, J., et al. (2021). High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review. Cells. DOI: 10.3390/cells10113164
  10. Bartkowiak-Wieczorek, J., et al. (2020). Relationship Between Adipocytokines and Angiotensin-Converting Enzyme Gene Polymorphism in Lean Women with and without Polycystic Ovary Syndrome. Gynecological Endocrinology. DOI: 10.1080/09513590.2019.1695248
  11. Bartkowiak-Wieczorek, J., et al. (2020). Effect of Different Water Extracts from Platycodon grandiflorum on Pathogenesis of Chronic Bronchitis in Rats. Molecules. DOI: 10.3390/molecules25215020
  12. Bartkowiak-Wieczorek, J., et al. (2020). Effect of Genetic Variations for Interleukin-10 on Efficacy of Immunosuppressive Therapy in Kidney Transplant Patients. International Immunopharmacology. DOI: 10.1016/j.intimp.2020.107059
  13. Bartkowiak-Wieczorek, J. (2020). The MDR1/ABCB1 Gene Polymorphism in Colorectal Cancer. Archives of Medical Science. DOI: 10.5114/aoms.2017.70329
  14. Bartkowiak-Wieczorek, J., et al. (2019). Effect of MDR1 and CYP3A41B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients*. Annals of Transplantation. DOI: 10.12659/AOT.914683
  15. Bartkowiak-Wieczorek, J. (2018). Demographic Factors Determining Folic Acid Supplementation in Pregnant and Childbearing-Age Women. Ginekologia Polska. DOI: 10.5603/GP.a2018.0036
  16. Bartkowiak-Wieczorek, J. (2018). Effect of Interleukin-6 Polymorphism on Renal Allograft Function and Immunosuppressive Therapy Efficacy. Farmacia. DOI: 10.31925/farmacia.2018.5.8
  17. Bartkowiak-Wieczorek, J., et al. (2018). Importance of New Generation Sequencing HLA Typing in Renal Transplantation—Preliminary Report. Transplantation Proceedings. DOI: 10.1016/j.transproceed.2018.05.005
  18. Bartkowiak-Wieczorek, J., et al. (2017). Effect of Salvia miltiorrhiza Root Extract on Brain Acetylcholinesterase, Butyrylcholinesterase Activities, mRNA Levels, and Memory in Rats. Physiology and Behavior. DOI: 10.1016/j.physbeh.2017.02.019
  19. Bartkowiak-Wieczorek, J. (2017). Role of the ITLN1 Gene Allelic Variant in Patients with Diabetic Foot. Polish Archives of Internal Medicine. DOI: 10.20452/pamw.4008
  20. Bartkowiak-Wieczorek, J., et al. (2017). Polymorphic Variants of Collagen 1A2 Gene in Osteopenia and Osteoporosis Development in Postmenopausal Women. Ginekologia Polska. DOI: 10.5603/GP.A2017.0077
  21. Bartkowiak-Wieczorek, J., et al. (2016). Analysis of Aldosterone Synthase and Atrial Natriuretic Peptide Gene Polymorphisms in Women with Preeclampsia. European Journal of Obstetrics and Gynecology and Reproductive Biology. DOI: 10.1016/j.ejogrb.2015.11.012
  22. Bartkowiak-Wieczorek, J. (2016). Association Between ACE Gene Polymorphism and Metabolic Disturbances in PCOS Women. Molecular Medicine Reports. DOI: 10.3892/mmr.2016.5910
  23. Bartkowiak-Wieczorek, J., et al. (2016). Influence of Melissa officinalis Leaf Extract on Long-Term Memory in Scopolamine Animal Model. Evidence-Based Complementary and Alternative Medicine. DOI: 10.1155/2016/9729818
  24. Bartkowiak-Wieczorek, J. (2016). Association Between Metabolic Syndrome Development in PCOS Patients and MTHFR Gene Polymorphism. Ginekologia Polska. DOI: 10.17772/gp/61751
  25. Bartkowiak-Wieczorek, J., et al. (2016). Antinociceptive and Anti-Inflammatory Effects of Oleanolic Acid and Aspirin Conjugate. Frontiers in Pharmacology. DOI: 10.3389/fphar.2016.00202
  26. Bartkowiak-Wieczorek, J. (2016). Importance of MDR1 Gene Polymorphisms in Colorectal Cancer Etiology. PrzeglÄ…d Gastroenterologiczny. DOI: 10.5114/pg.2015.51185
  27. Bartkowiak-Wieczorek, J., et al. (2016). Influence of TNF-α Polymorphism on Immunosuppressive Therapy Efficacy in Kidney Transplant Patients. Journal of Physiology and Pharmacology.
  28. Bartkowiak-Wieczorek, J. (2016). Significance of Genetic Polymorphisms in the RANKL/RANK/OPG Signaling Pathway in Postmenopausal Osteoporosis. Ginekologia Polska. DOI: 10.5603/GP.2016.0014
  29. Bartkowiak-Wieczorek, J., et al. (2015). Analysis of ADIPOQ Gene Polymorphisms in Women with Excessive Weight Gain During Pregnancy. Ginekologia Polska. DOI: 10.17772/gp/2421
  30. Bartkowiak-Wieczorek, J., et al. (2015). Evaluation of Anti-Inflammatory and Analgesic Activities of Extracts from Chelidonium majus L. Herb. Central European Journal of Immunology. DOI: 10.5114/ceji.2015.54607
  31. Bartkowiak-Wieczorek, J. (2015). *Gender-Specific Implications for Pharmacology in Women of Child